University of Arkansas, College of Medicine, Little Rock, AR 72205, USA.
Otolaryngol Head Neck Surg. 2010 May;142(5):722-7. doi: 10.1016/j.otohns.2010.01.026.
Study the survival of patients with cervical lymphatic squamous cell carcinoma recurrence.
Review of tumor registry database.
Academic health science center.
Forty-seven isolated neck recurrence patients identified from 224 recurrences from a total of 1291 patients treated between 1998 and 2007. The main outcome measurements were neck lymph nodal recurrence, treatment-specific survival, and overall survival.
A total of 47 patients had neck recurrence; 10 of the neck recurrence patients (21.3%) had regional disease (N+) at initial presentation. Median survival for patients with neck recurrence was 14.7 months (95% confidence interval [CI] 8.6-18.1 mo), and five-year survival for this group was five percent (95% CI 0%-30%). Neck dissection salvage therapy for neck recurrence resulted in the best survival.
Neck dissection as a salvage therapy for neck recurrence resulted in the best survival, and there was no survival benefit in terms of whether a patient had a neck dissection or not as his or her initial therapy.
研究颈淋巴结鳞状细胞癌复发患者的生存情况。
肿瘤登记数据库回顾。
学术健康科学中心。
从 1998 年至 2007 年间治疗的 1291 例患者的 224 例复发中,确定了 47 例孤立性颈复发患者。主要的观察指标是颈部淋巴结复发、治疗特异性生存率和总生存率。
共有 47 例患者发生颈部复发;10 例颈部复发患者(21.3%)在初次就诊时即有区域性疾病(N+)。颈部复发患者的中位生存时间为 14.7 个月(95%置信区间 [CI] 8.6-18.1 个月),该组的 5 年生存率为 5%(95%CI 0%-30%)。颈部复发的挽救性颈淋巴结清扫术治疗效果最佳。
颈淋巴结清扫术作为颈部复发的挽救性治疗方法可获得最佳生存,且作为初始治疗方法,患者是否接受颈淋巴结清扫术对其生存获益无影响。